(Q62821964)
Statements
A Phase 2, Randomised, Double-Blind, Placebo-Controlled Study of IC14 for Treatment of Patients With Rapidly Progressive Motor Neuron Disease (English)
0 references
15 August 2018
0 references
15 May 2020
0 references
50
0 references
18 year
0 references
75 year
0 references